Join the Rosacea group to help and get support from people like you.
Rosacea News
Related terms: Acne rosacea
Adult Acne Linked to Higher Risk for Eating Disorders
WEDNESDAY, April 30, 2025 – Adults with acne have a higher likelihood of having eating disorders, according to a letter to the editor published online April 16 in the Journal of the European Academy ...
Small Number of Acne Products Recalled for Problematic Levels of Benzene
THURSDAY, March 13, 2025 – After new U.S. Food and Drug Administration testing of acne products containing benzoyl peroxide, the agency determined that a small number of products should be recalled...
At-Home Light-Emitting Diode Devices Safe, Effective for Acne Treatment
THURSDAY, March 6, 2025 – At-home light-emitting diode (LED) devices are effective for treating acne, according to a research letter published online March 5 in JAMA Dermatology. Sherry Ershadi and ...
Ditch That Itch: Early Findings Offer Hope for Skin Issues Like Rosacea
THURSDAY, Dec. 12, 2024 – It's still early science – studies in mice and in human cells – but researchers are on the trail of an effective new treatment for inflammatory skin conditions such as...
FDA Approves Emrosi for Rosacea in Adults
TUESDAY, Nov. 12, 2024 – The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults. The extended-release capsules (40...
FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) – Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and mar...
Common Acne Drug, Benzoyl Peroxide, Might Become Carcinogenic at Room Temperature
WEDNESDAY, Oct. 9, 2024 – Widely-used acne creams can become contaminated with a known carcinogen even if kept at room temperature, a new study warns. Creams containing benzoyl peroxide (BPO) can...
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine
TUESDAY, July 16, 2024 – For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and...
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming Therapy
FRIDAY, June 7, 2024 – Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May...
FDA Approves Epsolay (benzoyl peroxide) Cream for the Treatment of Rosacea
NESS ZIONA, Israel and ZUG, Switzerland, April 25, 2022 (GLOBE NEWSWIRE) – Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing...
Allergan Announces FDA Approval of Rhofade (oxymetazoline hydrochloride) Cream for Facial Erythema Associated with Rosacea
DUBLIN, Jan. 19, 2017 /PRNewswire/ – Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today the approval of Rhofade cream by the U.S. Food and Drug Administration (FDA)...
FDA Approves Finacea (azelaic acid) Foam for Rosacea
WHIPPANY, N.J., July 31, 2015 /PRNewswire/ – Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam, 15% for the topical treatment...
Galderma Receives FDA Approval of Soolantra (ivermectin) Cream for Rosacea
FORT WORTH, Texas, December 23, 2014 --(BUSINESS WIRE)--Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) approved Soolantra (ivermectin) Cream, 1% for the...
Galderma Receives FDA Approval of Mirvaso for the Topical Treatment of Facial Erythema of Rosacea
FT. WORTH, Texas – August 26, 2013 – Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) has approved Mirvaso (brimonidine) topical gel, 0.33%* for the top...